The Patent Finder

Neogenix Oncology, Inc.

Also on record
Records under this name other than patents Neogenix Oncology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to Neogenix Oncology, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,829,678Recombinant Monoclonal Antibodies and Corresponding Antigens for Colon and Pancreatic Cancers
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,763,720Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
Formerly held
Term ended
Term ended Aug 22, 2026 · USPTO record
Term endedTerm ended Aug 22, 2026USPTO record
US 7,314,622Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
Formerly held
Term ended
Term ended Apr 14, 2026 · USPTO record
Term endedTerm ended Apr 14, 2026USPTO record
US 9,605,077Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
Formerly held
Term ended
Ended no later than Apr 14, 2026 · USPTO record
Term endedEnded no later than Apr 14, 2026USPTO record
US 9,034,588Monoclonal Antibody Therapy for Pancreas Cancer
Formerly held
Term ended
Term ended Apr 14, 2025 · Medium confidence
Term endedTerm ended Apr 14, 2025Medium confidence
US 8,470,326Monoclonal Antibody Therapy for Pancreas Cancer
Formerly held
Term ended
Term ended Jul 26, 2022 · Medium confidence
Term endedTerm ended Jul 26, 2022Medium confidence
US 7,491,801Identification and development of specific monoclonal antibodies to squamous cell carcinoma
Lapsed on the fee record
Ended Feb 17, 2013 · USPTO record
Lapsed on the fee recordEnded Feb 17, 2013USPTO record
US 5,688,657Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
Term ended
Term ended no later than Nov 18, 2017 · Low confidence
Term endedTerm ended no later than Nov 18, 2017Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited